Terry J Rosen insider trades: Arcus Biosciences (RCUS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Terry reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | RCUS | ↓ Sell | 54,691 | $22.01 | $1.2M | Direct | Dec 18, 2025 (1d) |
| Feb 27, 2025 | RCUS | ↑ Buy | 19,800 | $10.18 | $201K | Direct | Feb 27, 2025 (0d) |
| Dec 16, 2022 | RCUS | ↓ Sell | 13,043 | $30.75 | $401K | Direct | Dec 16, 2022 (0d) |
| Jun 17, 2022 | RCUS | ↓ Sell | 8,854 | $21.45 | $190K | Direct | Jun 21, 2022 (4d) |
| Dec 17, 2021 | RCUS | ↓ Sell | 5,242 | $40.12 | $210K | Direct | Dec 20, 2021 (3d) |
| Jun 17, 2021 | RCUS | ↓ Sell | 8,831 | $23.89 | $211K | Direct | Jun 21, 2021 (4d) |
| Aug 10, 2020 | RCUS | ↑ Buy | 43,705 | $22.86 | $999K | By The Rosen Family Trust | Aug 11, 2020 (1d) |
| Jun 6, 2019 | RCUS | ↑ Buy | 21,738 | $7.93 | $172K | By The Rosen Family Trust | Jun 7, 2019 (1d) |
| Jun 4, 2019 | RCUS | ↑ Buy | 25,770 | $7.75 | $200K | By The RosenFamily Trust | Jun 5, 2019 (1d) |
| Jun 3, 2019 | RCUS | ↑ Buy | 15,770 | $8.16 | $129K | By The Rosen Family Trust | Jun 5, 2019 (2d) |
| Aug 28, 2018 | RCUS | ↑ Buy | 18,607 | $15.07 | $280K | By Trust | Aug 29, 2018 (1d) |
| Aug 24, 2018 | RCUS | ↑ Buy | 9,289 | $13.45 | $125K | By Trust | Aug 24, 2018 (0d) |
| Aug 21, 2018 | RCUS | ↑ Buy | 8,891 | $13.24 | $118K | By Trust | Aug 21, 2018 (0d) |
| Aug 16, 2018 | RCUS | ↑ Buy | 28,401 | $12.64 | $359K | By Trust | Aug 16, 2018 (0d) |
| Aug 13, 2018 | RCUS | ↑ Buy | 9,929 | $11.87 | $118K | By Trust | Aug 13, 2018 (0d) |
| Mar 19, 2018 | RCUS | ↑ Buy | 66,666 | $15.00 | $1000K | By Trust | Mar 19, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCUS insiders
Open-market trades in the last 12 months
About Terry J Rosen's insider trades
Terry J Rosen is Chief Executive Officer at Arcus Biosciences (RCUS). Since Mar 19, 2018, Terry has reported 11 open-market purchases worth $3.7M and 5 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($1.2M).
Their filings also include grants and awards (17 filings), gifts (3 filings), shares withheld for taxes (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.